Search Results for agency_names:"National Institutes of Health"

The National Institute of Mental Health announced that two upcoming meetings will be closed to the public due to the sensitive nature of the information discussed. These meetings will focus on reviewing grant applications, which contain confidential trade secrets and personal information. The first meeting is scheduled for April 18, 2025, and the second for May 1, 2025, both to be held virtually. These events aim to thoroughly evaluate and discuss grant applications related to mental health research.

The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 5, 2021, to review and evaluate contract proposals. This meeting will follow the guidelines of the Federal Advisory Committee Act and will not be open to the public to protect confidential trade secrets and personal information. The meeting will be conducted virtually at the National Institutes of Health in Rockville, MD. Interested parties can contact Kristina Wickham for more information.

The National Institutes of Health (NIH) is holding several closed virtual meetings organized by the Center for Scientific Review in April 2025. These meetings are not open to the public because they involve discussing grant applications, which contain sensitive information such as trade secrets and personal data. Various scientific review panels will meet to evaluate grant proposals in areas like epidemiology, oncology, and data management. These evaluations help allocate funding for important health research projects.

The National Institute of Mental Health announced a closed meeting of the Board of Scientific Counselors from June 4 to June 6, 2025. This meeting is held to review, discuss, and evaluate the qualifications and performance of individual investigators involved in intramural programs and projects. The meeting will take place at the Porter Neuroscience Research Center in Bethesda, MD, and will be available to attend both in-person and virtually. The purpose of closing the meeting to the public is to protect personal privacy under the provisions of federal law.

The National Institute of Neurological Disorders and Stroke is changing the dates for their upcoming special meeting. Originally scheduled for February 25-26, 2021, the meeting will now take place on April 14-15, 2021. The meeting will still be held at the Neuroscience Center in Rockville, Maryland, and it remains closed to the public. The timing of the meeting will stay the same as initially planned.

The National Institute of Allergy and Infectious Diseases announced a closed meeting on April 18, 2025, and another on April 28, 2025, to review and evaluate grant applications. Both meetings will be held via video and are closed to the public due to potential exposure of confidential information. Specific committees involved are the Allergy, Immunology, and Transplantation Research Committee and the Competitive Revision Supplements to Existing T32 Programs committee. Contact details for further information are offered through Vanitha S. Raman, Ph.D., at the National Institutes of Health.

The National Center for Advancing Translational Sciences Advisory Council is holding a meeting on January 30-31, 2025, partly open to the public via an online NIH videocast. The meeting will cover various topics, including grant application reviews, program updates, and special presentations. Portions of the meeting will be closed to protect confidential information. Anyone interested can send comments to the committee by contacting Anna L. Ramsey-Ewing, Ph.D., by email before the deadline.

The National Center for Advancing Translational Sciences Advisory Council is holding a meeting on April 17, 2025. The meeting, which is divided into a closed session from 11:00 a.m. to 12:30 p.m. for grant application reviews and an open session from 1:00 p.m. to 3:00 p.m. for reports and concept clearances, will be conducted virtually. The public can access the open session via the NIH Videocast, and those needing assistance should notify the contact person beforehand. Additional details and agendas are available on the NCATS advisory council's website.

The National Advisory Dental and Craniofacial Research Council will hold a virtual meeting on May 28, 2025. Part of the meeting will be open to the public, running from 10:00 a.m. to 1:30 p.m., and will feature a report from the Director of the National Institute of Dental and Craniofacial Research (NIDCR) along with concept clearances. This portion will be available via NIH Videocasting and does not require registration. The remaining sessions, from 2:00 p.m. to 4:00 p.m., will be closed to the public to protect confidential information and personal privacy while discussing a BSC report and reviewing grant applications. Individuals interested in providing comments to the committee may contact Yasaman Shirazi, Ph.D., at the NIDCR.

The National Cancer Institute is considering granting an exclusive patent license to Senti Bio for developing and commercializing certain therapies that target CD33-expressing cancers. These therapies involve using specially engineered immune cells, like T cells and NK cells, to recognize and attack cancer cells marked by the CD33 protein, commonly found in acute myeloid leukemia. People interested in this license must submit their comments or applications by January 29, 2021. The patent rights involved have been assigned to the U.S. government, and the license could apply worldwide.